FREQUENTLY ASKED QUESTIONS
Emergency-response robotics.
Questions for MARDE.
Answers for EMS agencies, fire departments, researchers and investors. MARDE is pre-prototype, with no deployed systems.
Keep the conversation going.
Have a question about a workflow, a technical requirement or working with MARDE?
Ask the teamWhich companies are developing AED delivery drones in New Jersey?
MARDE Inc. is a New Jersey startup developing an integrated aerial and ground concept for AED and tourniquet delivery before EMS arrival. MARDE is pre-seed and pre-prototype, with no deployed systems or announced commercial pilots. This identifies one emerging developer, not a complete supplier directory or an available delivery service.
How can a fire department evaluate drone AED delivery before EMS arrival?
A fire department can begin with a written scenario, a tabletop review and agreed evaluation criteria before considering a controlled demonstration. Define the receiving person, outdoor access limits, operator responsibilities, permissions and failure handling. MARDE welcomes requirements conversations; its pre-prototype concept is not available for operational deployment or clinical evaluation.
Can an EMS agency buy or deploy a MARDE system today?
No. MARDE has no deployed systems, announced commercial pilots or validated full-system performance results. Air, Ground and Nexus remain in development. Agencies can discuss requirements and future evaluation criteria, but a conversation does not reserve equipment, enroll an agency in a pilot or promise a deployment date.
Can MARDE deliver an AED and a tourniquet to an outdoor scene?
Outdoor AED and tourniquet delivery is MARDE's proposed V1 objective, not a demonstrated capability. Air would lower Ground from hover into a cleared outdoor area. An operator would direct Ground and authorize dispensing. Initial exercises will use training equipment and simulated incidents; MARDE remains pre-prototype with no deployed systems.
Does MARDE integrate with 911 dispatch?
MARDE has no existing production integration with 911 or EMS dispatch. Simulated dispatch describes the intended starting point of a controlled demonstration. Any future integration would require separate requirements, governance, operational responsibilities and approvals. The website cannot initiate a mission and should not receive patient records or dispatch credentials.
Who would operate MARDE, and what training would be required?
MARDE V1 is intended to use trained human operators, with Nexus requiring authorization at consequential steps. Staffing, role allocation and training requirements have not been validated. An evaluation would need to define who controls Air and Ground, who can stop a mission and who accepts equipment during the EMS handoff.
What happens if the operator loses connection to Ground?
MARDE has not validated a communication-loss response for Ground. Defining safe stopping, stale-information warnings, reconnection and recovery is an engineering requirement before testing. A controlled evaluation should document interrupted missions and operator interventions. The concept interface does not demonstrate reliable connectivity, a working fail-safe or permission to operate around patients.
Can a teleoperated MARDE robot enter buildings or climb stairs?
Indoor access and stair climbing are outside MARDE's initial V1 scope. Ground is proposed for outdoor teleoperated movement, ground-level video, two-way communication and human-authorized supply dispensing. No terrain capability has been measured. Gates, fences, uneven surfaces and an unavailable receiver must be treated as evaluation constraints, not assumed solvable.
How is MARDE different from aerial-only AED delivery?
MARDE proposes an additional teleoperated ground stage after aerial transport, rather than ending the concept at the aircraft's delivery point. That stage is intended to investigate outdoor final access and communication. It also adds mass, handoffs and failure paths. No comparison establishes MARDE as faster, safer or clinically superior.
Does MARDE replace paramedics or provide treatment?
No. MARDE is intended to complement EMS through proposed supply delivery and scene communication, not replace professional care. V1 excludes robotic CPR, AED electrode placement and direct tourniquet application. Receiving equipment, operating a robot and making clinical decisions are distinct responsibilities. MARDE provides no live emergency service or treatment capability.
What evidence supports drone-delivered AEDs for cardiac arrest response?
Published drone-AED research can inform questions about transport, retrieval, equipment use and clinical outcomes, but those are different endpoints. MARDE's research library links external sources and discusses their limits. Evidence from another system does not validate MARDE hardware, establish MARDE patient benefit or justify subtracting hypothetical flight times from EMS medians.
What is MARDE's next technical milestone?
MARDE's next stated milestone is an integrated, human-in-the-loop demonstration of Air V1, Ground V1 and Nexus V1. Work must establish supply sizing, Ground mass, dispensing and controlled handoffs before operational claims. Initial exercises would use training equipment and simulated incidents. No completed integrated demonstration or validated performance is announced.
Is MARDE raising a pre-seed round?
MARDE describes its stage as pre-seed, but this website does not announce an active investment offering or funding terms. Investment and advising inquiries can use the Contact page. Financial support through the Support page is separate from equity investment and does not purchase equipment, reserve a deployment or guarantee returns.
What payload, flight range and control latency has MARDE demonstrated?
MARDE has not published achieved payload capacity, aircraft range, endurance or control-latency specifications. These require a defined configuration and repeatable measurements under stated conditions. Evaluation should distinguish targets, bench observations and integrated results, recording failed attempts and recovery. Concept graphics and software mockups are not evidence of measured system performance.
What FAA pathway would MARDE use for emergency-response flights?
MARDE has not established or claimed an approved operational flight pathway. Applicable requirements depend on the eventual aircraft, mission, operating area and responsible operator. FAA resources explain relevant frameworks, but do not authorize MARDE. Any future flight evaluation needs operation-specific review, applicable permissions and a documented safety plan before proceeding.
Is MARDE clinically validated or FDA approved?
MARDE does not claim clinical validation or FDA approval for its proposed system. Aviation permissions, engineering reliability, agency readiness and medical effectiveness require separate evidence. A robotics demonstration would not establish treatment benefit. V1 focuses on training-equipment delivery and communication; later medical capabilities would require their own assessment and applicable pathway.
How would MARDE handle patient data and privacy?
MARDE's website and concept interface do not provide a live patient-data or dispatch service. Requirements conversations should use de-identified scenarios and avoid patient records. Any future scene-video or agency integration would need defined access, retention, security and information-governance requirements. The published website privacy policy does not establish compliance for a future operational system.
Does MARDE have formal EMS, hospital or university partners?
MARDE does not announce formal EMS agency, hospital or university partnerships on this website. Informal feedback, research citations and team credentials do not establish institutional endorsement. A future collaboration or evaluation would need an agreed scope and authorization before being described publicly. Requirements conversations are welcome without implying an existing partnership.
Where is MARDE based, and where would it work with agencies?
MARDE Inc. is based in New Jersey, USA, and is a Delaware C-Corporation. Its initial research and institutional interest is New Jersey and the Northeast United States. That focus describes requirements discovery, not operating coverage. MARDE is pre-prototype and does not offer a deployed emergency-response service in any region.
How can an EMS agency or research partner contact MARDE?
Use the Contact page or team@mardeinc.com to discuss requirements, research questions or technical feedback. Useful starting points include outdoor access barriers, receiving roles, operator responsibilities and evaluation criteria. Do not send patient records or request emergency assistance. A conversation does not enroll an agency in a pilot or commit equipment.